Showing results (31-40 of 76) with videos related to
Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trialAllen M Goorin, Michael B Harris, Mark Bernstein, et al.EJNMMI Physics|December 14, 2020
Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patientsAmy J Weisman, Jihyun Kim, Inki Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's diseaseCameron K Tebbi, Wendy B London, Debra Friedman, et al.Blood|July 9, 2009
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425Cindy L Schwartz, Louis S Constine, Doojduen Villaluna, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group StudyJustine M Kahn, Kara M Kelly, Qinglin Pei, et al.Cancer|August 18, 2010
Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcomaDavid M Loeb, Robert F Hobbs, Amarachukwu Okoli, et al.Pediatric Blood & Cancer|April 5, 2021
Pediatric classical Hodgkin lymphomaAndrea C Lo, Karin Dieckmann, Tanja Pelz, et al.International Journal of Radiation Oncology, Biology, Physics|December 28, 2014
Patterns of relapse from a phase 3 Study of response-based therapy for intermediate-risk Hodgkin lymphoma (AHOD0031): a report from the Children's Oncology GroupKavita V Dharmarajan, Debra L Friedman, Cindy L Schwartz, et al.Blood Advances|January 4, 2018
Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphomaJennifer J G Welch, Cindy L Schwartz, Meghan Higman, et al.Cancer|January 19, 2012
Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology GroupKatherine A Janeway, Donald A Barkauskas, Mark D Krailo, et al.Pageof 8